Makale
Tam Makale
Uluslararası
2015
Frequency of Class I and II HLA alleles in patients with lung cancer according to chemotherapy response and 5-year survival
CLINICAL RESPIRATORY JOURNAL
Cilt 9 · Sayı 3 · ss. 297–304 · 01.07.2015
Özet
IntroductionLung cancer is the most common cause of cancer death in the world, and the most common type is non-small-cell lung cancer (NSCLC). At present, surgical resection, chemotherapy, and radiation therapy are the main treatments for patients with NSCLC, but unfortunately outcome remains unsatisfactory.
Anahtar kelimeler
SURVIVAL
EXPRESSION
PROLIFERATION
VIVO
LUNG-CANCER
SOLID TUMORS
drug resistance
Interferon
CARCINOMA
Class I and II HLA alleles
response to chemotherapy
INFLAMMATORY FACTOR-I
PROGNOSTIC-FACTOR
ANTIGEN
Sürdürülebilir Kalkınma Amaçları
-
SKA 3: Sağlıklı Bireyler
Atıf için künye
Araz, Ö., Yılmazel Uçar, E., MERAL, M., Yalcin, A., ACEMOĞLU, H., DOĞAN, H., Karaman, A., Aydın, Y., Gorguner, M., & AKGÜN, M. (2015). Frequency of Class I and II HLA alleles in patients with lung cancer according to chemotherapy response and 5-year survival. CLINICAL RESPIRATORY JOURNAL, 9(3), 297–304. https://doi.org/10.1111/crj.12143
BibTeX
@article{araz2015-214141,
author = {Araz, Ömer and Yılmazel Uçar, Elif and MERAL, Mehmet and Yalcin, Aslihan and ACEMOĞLU, Hamit and DOĞAN, Hasan and Karaman, Adem and Aydın, Yener and Gorguner, Metin and AKGÜN, Metin},
title = {Frequency of Class I and II HLA alleles in patients with lung cancer according to chemotherapy response and 5-year survival},
journal = {CLINICAL RESPIRATORY JOURNAL},
year = {2015},
volume = {9},
number = {3},
pages = {297--304},
issn = {1752-6981},
doi = {10.1111/crj.12143},
url = {https://akademik.atauni.edu.tr/yayinlar/214141-frequency-of-class-i-and-ii-hla-alleles-in-patients-with-lung-cancer-according}
}